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vivo has been shown comparable to that of 
autologous bone.[3,4] Indeed, CaPs are con-
sidered bioactive materials, meaning that 
they are able to elicit or modulate the bio-
logical activity.[5] In a bony environment, 
the bioactivity of CaPs encompasses their 
bone-bonding capacity, osteoconductivity, 
and in some cases, osteoinductivity. While 
it may seem straightforward that their 
chemical composition is the key factor for 
their bioactivity, it should be emphasized 
that CaPs are complex functional bioma-
terials, with a set of largely intertwined 
physico-chemical and structural proper-
ties, many of which have been reported 
to affect the biological response to these 
materials. For example, surface micro-
structure,[6–8] particle size-[9–13] and mor-
phology,[10,11,14] grain size,[15–17] surface 
energy and wettability,[18–20] porosity,[17,21] 
pore size and shape,[21] phase composi-
tion,[14,22] crystallinity[23,24] and stiffness[25–27] have all been 
shown to influence the bone regenerative capacity of CaPs.
While different properties of CaPs are known to affect 
their bioactivity, it should be mentioned that already the very 
first contact of the material with the biological environment is 
largely dependent on the material properties. Upon implanta-
tion in a bone defect, the initial interaction of the biomaterial 
surface with the biological environment occurs via contact with 
blood, leading to the formation of a blood clot that supports the 
healing process,[28] and that is known to contain platelets, eryth-
rocytes and leukocytes.[28,29] The process of blood clot formation 
is influenced by the physicochemical properties of the material. 
For example, surface roughness is determinant for the process 
of protein adsorption on the surface, which in turn facilitates 
platelet adhesion and activation, and eventually controls the 
bone healing process.[30,31]
Furthermore, the bioactivity of CaPs in vivo is closely related 
to their degradation, by means of physico-chemical dissolu-
tion as well as resorption via cellular mechanisms.[32,33] The 
activated platelets release growth factors, such as platelet factor 
4 (PF-4), platelet-derived growth factor (PDGF) and trans-
forming growth factor beta (TGF-β),[28,34] which stimulate the 
chemotaxis of inflammatory cells like neutrophils and mono-
cytes (with the ability to differentiate into macrophages and 
osteoclasts), favoring their migration towards the site of implan-
tation.[35] In addition, proliferation of osteoblasts, as well as 
the migration and proliferation of other bone marrow-derived 
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1. Introduction
Calcium phosphate (CaP)-based ceramics are currently the most 
widely applied synthetic biomaterials for repair and regenera-
tion of damaged and diseased bone, and their use is expected to 
further increase. Currently a few million bone graft procedures 
are performed worldwide each year,[1] as a treatment of bone 
defects caused by trauma or tumor removal, and spinal fusion. 
An increasing need exists for effective and affordable bone graft 
substitutes, and CaPs have the potential to play a pivotal role in 
a socially responsible tissue engineering.[2] The production and 
storage of CaPs are inexpensive as compared to growth factors- 
or cells-based strategies, and their chemical composition, mainly 
calcium and phosphate, resembles that of natural bone mineral, 
simplifying the regulatory path towards clinical application.
Some distinct clinical successes have been achieved with 
CaPs, and in a few studies, the bone regenerative potential in 
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cells occurs.[30,36,37] The resorption processes is often pre-
ceded by the process of chemical dissolution or mechanical 
degradation, whereby material particles are released from the 
implant, interacting with the inflammatory cells, which then 
become activated and release inflammatory mediators.[32,33] 
Depending on the size of the particles, they will be processed 
by phagocytosis and intracellular digestion by the macrophages 
(size below 10 micrometers), giant cells (size between 10 and 
100 microme ters), or through extracellular degradation by mac-
rophages or foreign body giant cells (FBGCs) if the particle 
size is larger than 100 micrometers.[32,38] Furthermore, direct 
resorption by osteoclasts can occur on the surface of some 
CaPs, a process that is, among others, dependent on the chem-
ical phase of the ceramic and the presence of dopants.[32,39]
Elucidating the role of each individual material property 
on the biological response to the material is of utmost impor-
tance for designing and developing new, more efficient bone 
graft substitutes. Indeed, understanding the role of the indi-
vidual properties and designing new materials that encompass 
a combination of the desired properties would change the way 
synthetic bone graft substitutes are currently developed, which is 
largely based on trial-and-error experiments. Nevertheless, three 
main obstacles can be defined that hamper the understanding 
of the role of individual properties in affecting the biological 
response to a material. First, a thorough and adequate charac-
terization of the material properties is crucial to make a com-
parison among different materials and different studies. Never-
theless, most studies focus on characterizing only a limited set 
of properties, thus neglecting the influence of the rest of them.
Second, there is a large variety of methods to assess the bio-
logical performance of a given biomaterial, making the com-
parison of the results difficult. In vitro studies with stem cells or 
(pre)osteoblast (-like) cells and the measurement of the expres-
sion of osteogenic markers at the mRNA level, such as alkaline 
phosphatase (ALP), osteopontin (OP) or osteocalcin (OC) is a 
common procedure for the evaluation of cell differentiation,[40] 
although the use of different cell types prevents a reliable compar-
ison of the results from different studies. Other researchers focus 
more on protein adsorption[19,24,41,42] or osteoclast activity.[7,43–46] 
In vivo studies add additional challenges, as animal models 
suffer from interspecies[47] and intraspecies[48] variations, while 
the model itself is also largely determinant for the outcome.
Third, in contrast to polymers, the chemistry or topography 
of which can be, to a certain extent, tuned individually without 
affecting the other parameters, the properties of ceramic mate-
rials are difficult to control independently during the synthesis 
process.[49,50] For example, it is very difficult to change the 
chemical composition of CaPs without affecting their crystal 
structure or morphology,[51] or the micropore size without 
changing the total porosity.[17] Therefore, any experiment 
designed to correlate the effect of an individual property with 
a certain biological response is largely affected by this entangle-
ment of the properties (Figure 1).
Nevertheless, recently, a number of strategies have been devel-
oped as an attempt to decouple the role of individual material 
properties in bone regeneration. Yet, the use of different strat-
egies may lead to different conclusions. For example, in our 
recent study,[52] the decoupling of the effect of topography and 
chemistry led to the conclusion that the effect of chemistry on the 
osteogenic differentiation of human mesenchymal stromal cells 
(hMSCs) was more important than that of the topography, while 
in a study using a different strategy and osteoblast-like cells,[53] 
topography seemed to be the main factor influencing the expres-
sion of osteogenic markers. Similarly, while the results of some 
studies support the hypothesis that surface chemistry is the most 
important factor,[52,54,55] others stand for a predominance of the 
effects of surface structure.[55,56] Decoupling the properties also 
implies the loss of the possible synergistic effects among them, 
which have been suggested to exist.[57,58] For instance, the incor-
poration of only calcium or only phosphate ions instead of CaP 
into a polymer to form a composite material allowed to evaluate 
the individual effects of the ions on the proliferation and osteo-
genic differentiation of hMSCs, but the potential synergistic 
effects of the chemistry and topography were lost.[59]
This progress report reviews the strategies developed to 
understand the roles of chemical (CaP phase, presence of 
additives, individual ions, release kinetics), physical/structural 
(crystal structure, crystallinity, surface energy, particle size 
and shape, grain size, surface roughness, porosity, pore size 
and shape) and mechanical properties, along with the results 
obtained for their influence on the biological response to the 
material. We discuss the advantages and the possible downsides 
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of the selected strategies. The aim of this report is to provide a 
better insight in the effects of individual material properties on 
the bone regenerative potential of synthetic bone graft substi-
tutes, which may be useful for developing new materials.
2. Role of Physical Properties
2.1. Structural Properties
Understanding the influence of the structural properties of 
CaP-based biomaterials for bone repair and regeneration on 
their performance is still a challenge, given that it is difficult, 
if not impossible, to change the surface topography without 
affecting the surface chemistry.[60] To provide a definitive 
answer regarding the individual contribution of these prop-
erties on the bioactivity of the biomaterial, we have recently 
employed a range of techniques, including soft lithography 
and various coating methods,[52] to decouple and subsequently 
recombine the chemical and surface topography effects of bio-
mimetic crystalline CaPs.
There are several surface topographical parameters that have 
been suggested to affect the in vitro and in vivo performance 
of CaP bone graft. Surface roughness is usually characterized 
through Ra, which is the mean deviation of the height on the sur-
face measured along a line profile, and Sa, i.e. the mean deviation 
of the height on an area, that is considered a more representative 
and descriptive parameter than Ra.[60,61] Surface roughness has 
been reported to affect both in vitro[7,8,54,62–64] and in vivo[56,65] 
performance of the bone graft substitutes. The suggested 
mechanisms behind this effect seem to be similar in vitro and 
in vivo. In vitro, it has been reported that rougher surfaces pro-
mote protein adsorption[66,67] and facilitate cell attachment and 
proliferation,[8] while in vivo the roughness has been shown to 
additionally affect the inflammatory response to the material.[68]
The porous nature of the structure has also been widely 
reported to have an effect on processes related to bone regen-
eration. Porous structure is usually characterized by two param-
eters, the pore size and the porosity. It has been shown that 
in vivo the proteins accumulate inside the micropores and 
ion-exchange through dissolution and (re)precipitation are 
facilitated.[69–71] Macropores are the key factor for the migration 
and proliferation of (pre)osteoblasts and the facilitation of the 
angiogenesis, as a network of interconnected pores, in general 
larger than 50 µm[58,69,72–74] is required to allow the formation 
of blood vessels.[69,75,76]
Adv. Healthcare Mater. 2017, 6, 1601478
Figure 1. The material properties of calcium phosphates are highly intertwined. A change in the chemical composition, e.g. by substitution of an ion 
in the crystal lattice, results in a modification in the crystalline structure that affects the surface topography, and at the same time the mechanical 
properties. Similarly, an attempt to modify the mechanical properties by controlling the sintering parameters results in a modification of the porous 
structure, surface topography as well as phase composition.
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An increase in crystallinity has been reported to reduce the 
reactivity of CaP,[23,77,78] including dissolution, thereby affecting 
their biological performance. As reported by ter Brugge et al.,[79] 
the effect of CaP crystallinity and associated solubility both in 
vitro and in vivo is still controversial. In vitro, some studies 
found that amorphous materials promote proliferation and 
differentiation of mouse fibroblasts and rat calvarial cells,[80,81] 
while others stated that the higher dissolution rate of amor-
phous materials can result in cytotoxicity due to the elevated 
ion concentration.[23,79,82] In vivo, highly crystalline CaP have 
been reported to enhance new bone formation or to hamper 
it.[83–85] The crystallinity of CaP can be changed by modifying 
the synthesis and/or sintering procedure, and, again, it is likely 
that by doing so other parameters will change as well, which 
may lead to the different conclusions about its role in the bio-
logical performance of CaP that are described above. Although 
the parameters grain size and particle size are frequently inter-
changeably used, they refer to different properties of crystalline 
materials. Whereas a grain is defined as a region, mono- or 
polycrystalline, where the crystal or crystals have the same 
lattice orientation, a particle is an agglomerate and can contain 
multiple grains. Both grain- and particle size have been shown 
to affect cell behavior, although their effects are very difficult to 
decouple from the effect of surface roughness, as an increase in 
grain size generally leads to an increase in surface roughness.
The presence of artificial, often machined, micro- and nano-
structured patterns on the biomaterial surfaces seems also to 
affect the biological response,[86] and even at the nanoscale, 
patterns have been shown to have the potential to control the 
osteogenic differentiation of MSCs in vivo.[87]
2.1.1. Coating Methods to Isolate the Effect of Surface  
(Micro)Structure
This strategy employs “masking” of the surface chemistry 
of CaPs by depositing a thin layer of another material on the 
ceramic surface with the aim to isolate or at least highlight the 
role of the surface structural features (Figure 2.1). Obviously, 
this method eliminates the influence of the CaP surface 
Adv. Healthcare Mater. 2017, 6, 1601478
Figure 2. Strategies to decouple the role of topography from other material properties. 1) Coating of a CaP ceramic with a thin layer of other material, 
e.g. gold, to retain the surface structural properties of the ceramic while changing the surface chemistry. 2) Fabrication of structural analogs of crystalline 
CaPs in a polymer using soft embossing. Adapted with permission.[52] 3) A schematic representation of the process of surface micropatterning with CaP 
ceramics by micromoulding in capillaries, including a) casting of polydimethylxyloxane (PDMS) and curing to develop a mould, b) air plasma treatment, 
c) infiltration of a CaP solution into the channels, d) drying and e) mold removal. Adapted with permission.[105] 2015, the Royal Society of Chemistry.
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chemistry but it introduces the chemistry of the coating mate-
rial. Therefore, biocompatible but inert materials, such as 
gold or palladium, are generally preferred for this application, 
despite a few reports on the negative effects of these inert mate-
rials on cell proliferation and differentiation, as compared to 
titanium coatings.[55,88] It should be mentioned that the use of 
line-of-sight coating methods, i.e. methods in which only sur-
faces that are exposed to the source of the coating material, 
such as plasma spraying or most physical vapor deposition 
techniques,[89,90] have the important disadvantage of leaving 
some areas uncoated, in particular in the case of geometri-
cally complex or porous structures.[89–91] In these cases, the 
effect of the underlying chemistry cannot be fully eliminated. 
Therefore, non line-of-sight techniques, such as chemical 
vapor deposition (CVD), electrodeposition or solution-based 
biomimetic methods, are preferred within the context of iso-
lating the effect of surface structure.[92–94] In the work by Dos 
Santos et al.,[55] a gold coating with a thickness of 20 nm was 
applied to the surfaces of hydroxyapatite (HA) and tricalcium 
phosphate (TCP), two widely used CaP bone graft substitutes, 
having a high density in order to avoid the additional effects 
of surface microporosity. Although the effect of calcium and/
or phosphate ions that diffused through the, not fully homog-
enous, gold layer could not be completely excluded, the authors 
were able to demonstrate that the effects of nanoroughness 
on the adhesion of human osteoblastic cells SaOs2 were neg-
ligible, while nanoroughness significantly affected cell pro-
liferation and differentiation. Cairns et al. deposited thin CaP 
films on top of glass substrates having different topographies 
produced by magnetron sputtering deposition of polycrystal-
line titanium, and then applied a second layer of fibronectin, an 
extracellular matrix protein known to bind to implant surfaces 
in vivo.[95] Upon culture of MG-63 osteosarcoma cells on such 
coated materials, effects on cell attachment, proliferation and 
differentiation were observed not only as a result of the pres-
ence of the fibronectin layer, but were also shown dependent on 
the nanoscale topographical features underlying the CaP layer. 
Pegg et al. applied a thin sputter-coated gold layer over the sur-
face of titanium alloy substrates coated with an HA coating, by 
using the commercially available BoneMaster biomimetic tech-
nique.[96] While the surface topography between the uncoated 
and HA-coated titanium alloy substrates was significantly dif-
ferent, the gold coating did not affect surface roughness. Fur-
thermore, the analysis of the surface chemistry using x-ray 
photoelectron spectroscopy (XPS) confirmed that no calcium or 
phosphate ions were present on the gold-coated samples. Cell 
proliferation, as well as ALP and OC expression levels were 
higher on HA-coated than on the uncoated metal, while no 
significant differences were found between the gold-sputtered 
HA-coated titanium alloy and HA-coated titanium alloy without 
the gold coating. Based on this, the authors concluded that the 
topography is the main contributing factor in the osteogenic 
differentiation of cells on these surfaces. Nevertheless, it was 
impossible to completely exclude the possible leaching of cal-
cium and phosphate ions from the gold-coated samples, which 
could also have affected the growth and differentiation of the 
cells. In a subsequent clinical trial, 55 patients received an 
uncemented femoral stem coated with a layer of HA deposited 
either using the BoneMaster technique or by plasma spraying. 
After five years, there was no clinically relevant difference 
between the two groups of patients.[97] The coating method for 
decoupling the effects of surface chemistry from that of the 
surface structure was evaluated in vivo in a study by Hacking 
et al.[56] Titanium implants with a plasma-sprayed HA coatings 
were coated with an ultrathin titanium layer using physical 
vapor deposition, and implanted in a canine femoral intramed-
ullary implant model. The analysis of the surface chemistry of 
the implants, made by XPS, did not show any remnants of HA 
on the surface, that is, the only influence on the surface chem-
istry was due to the titanium coating. The comparison between 
the two groups of implants, titanium coated with HA and tita-
nium coated with HA and subsequently with titanium led to 
the conclusion that 80% of the maximum bone formation was a 
direct effect of the surface topography.
2.1.2. Replication of the Calcium Phosphates Structure in  
Other Materials
Another possibility to decouple the role of the surface struc-
ture from that of the surface chemistry is to fabricate a replica 
of a given biomaterial in another material with different sur-
face chemistry. The majority of studies employing this method 
were performed on titanium, which is a widely used material 
for medical devices, such as total hip implants.[98,99] Wieland 
et al. fabricated replicas in epoxy of titanium surfaces varying in 
roughness.[98] A combination of non-contact laser profilometry 
(LPM) and stereo-SEM was used to prove that there were no sta-
tistically significant differences in surface roughness between 
the Ti surfaces and the epoxy replicas in the wavelength range 
from 100 nm to 1 mm. The authors were able to demonstrate 
that the roughness, independently of the chemistry, affected the 
morphology and thickness of cultured human fibroblasts.[98] 
In another study, they coated the titanium replicas in epoxy 
with a thin titanium layer by applying physical vapor deposi-
tion, thereby faithfully reproducing the surface topography and 
chemistry of the original titanium substrates.[99] Rat calvarial 
osteoblast, cultured for 24 h on smooth and rough coated rep-
licas, showed no differences in cell number, footprint area or 
cell morphology.
In recent studies,[52,100] replicas in cyclic oleofin copolymer 
(COC) of crystalline biomimetic CaPs and of microstructured 
CaP/polylactic acid (PLA) composites were produced using 
a soft embossing technique applying an intermediate polydi-
methylsiloxane (PDMS) mold (Figure 2.2). The structures were 
reliably reproduced in polymer down to the submicrometer 
level, thus obtaining a material with same surface topography 
but different surface chemistry. In order to recover the effect of 
the surface chemistry, some of the replicas in COC were subse-
quently coated with a thin amorphous CaP layer or, to introduce 
an alternative chemistry, with a thin titanium layer. The results 
of the hMSC culture on uncoated and coated replicas indicated 
that the chemical effect, i.e. the effect of the presence of CaP, 
was more pronounced that the microstructural effect, in terms 
of the differentiation of hMSCs into the osteogenic lineage.
A criticism to this strategy may be that the replicas in dif-
ferent materials not only have different surface chemistry, 
but consequently also different mechanical properties and 
Adv. Healthcare Mater. 2017, 6, 1601478
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wettability, which has also been shown to have an effect on 
the cell behavior. An attempt to decouple the effect of the 
chemical composition from that of the mechanical properties is 
addressed in a later section of this report.
2.1.3. Surface Structure Modification
The modification of the surface structure after the synthesis and/
or sintering process is a possible way to study the effect of micro- 
and nanostructure of CaPs. There are different surface modifi-
cation methods, such as polishing, grinding, sandblasting and 
etching. These methods of surface modification, however, may 
simultaneously affect more than one parameter; for example 
the polishing process may not only reduce the surface rough-
ness, but also affect the porosity of the surface or the grain size. 
Therefore, a meticulous characterization is needed to attribute 
the change in cell- or tissue response to a single property.
Deligianni et al. fabricated HA pellets and polished them 
after sintering to achieve three different surface roughness 
levels.[8] The analysis of the phase composition by x-ray dif-
fraction (XRD) showed that the three different samples were 
all composed of pure HA. However, no analysis of the change 
in surface porosity or grain size was performed. There were 
no differences in cell number, morphology or ALP expres-
sion levels of cultured bone marrow-derived hMSCs among 
the three groups of materials. In contrast, cell attachment 
and the force required for the detachment increased with the 
increase in surface roughness.
In another study, Li et al. produced biphasic CaP (BCP) 
discs, consisting of HA and β-TCP, and polished them to 
achieve different surface roughness.[101] The discs were then 
used to study the behavior of three different cell types: C2C12, 
a myoblast cell line, primary bone marrow-derived hMSCs and 
MC3T3-E1, an osteoblast cell line. The discs used for the study 
not only differed in surface roughness, but also in crystal size 
and microporosity, making a reliable comparison challenging. 
Nevertheless, in contrast to the study by Deligianni et al.,[8] cell 
attachment, although dependent on the cell type, was not sig-
nificantly affected by the surface roughness. As a conclusion, 
surface roughness was not considered an important factor in 
cell behavior.
A similar procedure was followed by Mazón et al., who poli-
shed α-TCP ceramic discs to vary surface roughness without 
affecting the chemical composition.[102] The material charac-
terization procedure included XRD, x-ray fluorescence (XRF), 
surface profilometry and scanning electron microscopy (SEM). 
Adult hMSCs were cultured on the discs, and the results 
showed that cell proliferation and differentiation were signifi-
cantly affected by the difference in surface roughness.
2.1.4. Patterning
Rather than relying on methods such as polishing or etching 
that result in an average value for e.g. surface roughness, 
derived from structural features over a larger area, patterning 
is an elegant way to obtain biomaterial surfaces with finely con-
trolled features in terms of properties and spatial distribution. 
Although this technique has so far not been extensively used 
for decoupling the roles of chemistry and topography of CaPs, it 
is worth mentioning it here for its great potential in designing 
parametric studies. Structural patterning has already been 
widely used for polymeric biomaterials,[103] since polymers are 
more amenable to various patterning techniques as compared 
to brittle and hard ceramic materials. Nevertheless, several 
techniques, such as micromachining or laser ablation, have 
been used to obtain patterned surfaces in (bioinert) ceramics, 
although their accuracy is below 100 µm.[104,105] The use of 
microfabrication technologies, such as soft lithography, allows 
for ceramic patterning with higher accuracy. Pelaez-Vargas 
et al.[106] used a combination of soft lithography and sol-gel pro-
cessing to produce anisotropic silica microtextures with varying 
spatial density, followed by culture of human osteoblast-like 
cells. Cell alignment was remarkably influenced by the effect of 
the surface topography. Cell metabolic activity and osteogenic 
differentiation measured by ALP activity were also affected by 
the density of the patterns, with the lower-density topographies 
showing the significantly higher values that the flat controls. 
A photolithography-based method was used by He et al. to pro-
duce patterns of HA in the shape of micro-islands on a poly-
ethylene glycol (PEG)-passivated glass substrates.[107] The HA 
patterns were obtained by precipitation from simulated body 
fluid (SBF), and had, according to XRD data, a relatively low 
crystallinity. The culture of MC3T3-E1 cell line on the patterned 
substrates showed that the cell adhesion took place exclusively 
on the HA micro-islands. The authors proposed micropat-
terning as a method to decouple chemical from geometrical 
cues in CaP. A recent paper by Barata et al.[105] reported pat-
terning of CaP (dicalcium phosphate anhydrous (DCPA) and 
β-TCP) on silicon substrates using a soft lithography approach 
(Figure 2.3). The linear ceramic patterns consisted of elongated 
crystals with radially branching morphology, occupying the 
volume of the channels used for the infiltration of the mineral 
solution. While the formation of the patterns was successful, 
further optimization is required to improve the homogeneity of 
the patterns and to better control the properties of the ceramic 
phase. Nevertheless, the alignment, morphology, and the reten-
tion of the morphology in time of MG-63 osteosarcoma cells 
were affected by the dimensions of the ceramic patterns.
2.1.5. Control Over the Porosity
In conventional sintered ceramic materials, the final porosity 
depends on the porosity of the green body and the sintering 
temperature. Therefore, two different methods (and their com-
binations) have been developed to achieve control over the 
porosity: the modification of the green body by creating arti-
ficial pores or by introducing porogens prior to the sintering 
process (Figure 3),[108] and the modification of the sintering 
temperature. Ideally, the porogens should be substances that 
are removed during the sintering process, leaving pores behind. 
The modification of the sintering route generally also affects 
several other material properties, such as the phase composi-
tion or the grain size.
Yuan et al. produced two different porous bioceramics, 
HA and BCP, by introducing different porogens such as 
Adv. Healthcare Mater. 2017, 6, 1601478
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naphthalene and wax particles in order to achieve controlled 
porosity and pore size.[109] Both HA and BCP had macroporous 
structures, but the surface of the macropores in BCP contained 
abundant micropores, while the surface of HA macropores was 
dense and showed no microporosity. The ceramics were shaped 
as cubes and implanted intramuscularly in a goat model. The 
results showed that all the BCP implants were able to induce 
new bone formation, while the macropores of HA were filled 
with fibrous tissue, without bone. As the authors acknowl-
edged, this study compared two ceramics, the material prop-
erties of which differed in more than one parameter, namely 
the chemical phase and the surface microstructure, making a 
reliable comparison difficult. In two other studies,[4,110] BCP 
ceramics were sintered at different temperatures, 1150 and 
1300 °C; the increase in sintering temperature led to materials 
with lower microporosity but also different volume distribu-
tion of the pores and larger average grain size. Additionally, 
differences in sintering temperature are also likely to modify 
the phase composition of the surface and the bulk of the mate-
rial.[111,112] Upon implantation in a posterolateral spinal fusion 
model in dog[4] and in a paraspinal muscle goat model,[110] 
both studies found that bone formation was 
induced in the material with higher micro-
porosity, i.e., those which were sintered at 
1150 °C. These results suggest that the dif-
ference in bone formation was caused by 
the change in the structural properties, how-
ever, the question to which of the structural 
properties this effect can be attributed, and 
to which extent, remains unanswered. In a 
similar study, two different types of ceramics, 
HA and BCP, were fabricated with different 
microporosity and crystal size through vari-
ations in the sintering temperature.[113] The 
phase composition in both HA and BCP did 
not change with the increments in sintering 
temperature, but the microporosity dimin-
ished and the crystal size increased, thus 
the specific surface area was lower in the 
ceramics sintered at higher temperatures. 
The results of an in vivo experiment testing 
ectopic bone formation potential suggested 
that an optimal specific surface area exists at 
which the amount of newly formed bone is 
maximal.[113]
Klenke et al. produced BCP particles with 
different macropore sizes by using naph-
thalene particles of different dimensions 
as porogens and hydrogen peroxide for cre-
ating micropores, while keeping the overall 
porosity constant.[76] The ceramic bodies were 
implanted in critical-sized cranial defects in 
mice, showing that angiogenesis, followed 
by bone formation, was mainly stimulated 
in samples having the pores with a size over 
140 µm. Another example of the use of poro-
gens to control the porosity was provided by 
Kasten et al.,[21] who analyzed the effect of 
the porosity of β-TCP scaffolds on the in vitro 
behavior of hMSCs, as well as on in vivo bone formation of the 
same scaffolds loaded with hMSCs in a subcutaneous mouse 
model. The results showed that in vitro, an increase in porosity 
increased the protein production, but it did not influence ALP 
expression levels, i.e., osteogenic differentiation. In vivo, while 
no effect of the porosity was observed on the ALP expression, 
scaffolds with a higher porosity exhibited a more pronounced 
mineralization by the cells.
In order to decouple the effects of microporosity from 
those of grain size, in an elegant study Lapczyna et al. devel-
oped four different TCP ceramics, with independent variation 
of these properties.[17] Two different porogens were used: PEG 
particles for the generation of macropores, and stearic acid and 
wheat flour with a bimodal size distribution to vary micropore 
sizes. Different sintering routes were used to obtain different 
grain sizes and maximize the purity of the phase composition. 
Although the aim was to obtain samples that are phase-pure 
β-TCP, some of the samples contained up to 16 wt.% α-TCP. 
Furthermore, the micropore size distribution differed among 
the samples, showing that it is very difficult, if not impos-
sible, to vary a single parameter in CaP ceramics, by employing 
Adv. Healthcare Mater. 2017, 6, 1601478
Figure 3. Use of porogens to elucidate the role of properties of porous structure in CaP bioac-
tivity. 1) Porogens are incorporated to the green body, and during the sintering process they are 
removed, resulting in a porous structure. The use of porogens of different sizes and in different 
amounts allows to tune the size distribution and porosity of the structures. 2) SEM images of 
β-TCP ceramics with different pore sizes produced by the use of PMMA porogen particles with 
different diameters. Reproduced with permission.[108] 2008, Elsevier.
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conventional production techniques. Nevertheless, the mate-
rial characterization in this study was highly comprehensive, 
including XRD, SEM, micro computed tomography (micro-
CT), mercury porosimetry, and measurement of the density 
and specific surface areas, which is of utmost importance in 
correlating the properties of a material to a biological response. 
The materials were implanted in proximal and distal humerus 
and femur defects is sheep,[114] and the amount of bone formed 
after the implantation was evaluated by means of micro-CT 
image analysis. The results showed that there were no signifi-
cant differences between the different implants, despite their 
different structural parameters. These results are in contrast 
with other studies in which the effects of microporosity and 
grain size of CaPs were investigated. Besides several studies 
previously mentioned in this section, Chan et al. implanted 
silicon-substituted CaP ceramics with different microporosities 
in an ectopic sheep model for 24 weeks, finding that the level 
of bone formation was significantly higher in the ceramics 
with higher porosity.[73] In a study by Hong et al.,[115] BCP and 
HA with different grain sizes were implanted into thigh bones 
of dogs, showing that in BCP, an increase in the grain size 
(from 86 nm to 768 nm) had a positive effect to the amount 
of newly formed bone, whereas in HA, a grain size increase 
from 115 nm to 731 nm did not strongly affect the amount of 
new bone formation, suggesting that the effect of grain size is 
dependent on the chemistry of the ceramic.
The differences in the results obtained from different 
studies may be attributed to the fact that the final biological 
response is more dependent on biological factors than on 
material properties.[17] Taking a more deterministic perspec-
tive, we should reflect on the effects of the animal model, the 
sometimes incomplete material characterization that might 
mask changes in multiple properties beside those being the 
object of the study, or the experimental design, including the 
strategy chosen to decouple the role of the different properties. 
Therefore, it seems necessary to improve the decoupling strate-
gies reviewed in this section. This could be achieved by devel-
oping and employing alternative fabrication techniques able to 
provide a more precise control over the ceramic synthesis and 
sintering process, such as the microwave sintering reported 
by Hong et al.,[115] the slip-casting shaping method developed 
by Feng et al.,[116] or by using other techniques able to create 
pores in the ceramics without modifying other properties, such 
as additive manufacturing techniques allowing to customize 
and control the pore structure of bone graft substitutes.[117,118] 
For example, Tarafder et al. 3D-printed TCP scaffolds with con-
trolled interconnected porosity and different pore sizes (500, 
750 and 1000 micrometers), sintered them using two different 
methods (conventional sintering furnace at 1150 °C and micro-
wave sintering at 1250 °C, both resulting in a decrease of pore 
size) and tested them in vitro using human osteoblast cells and 
in vivo by implantation in femoral defects of Sprague-Dawley 
rats.[119] In vitro, the ceramics with smallest interconnecting 
pore size showed the most pronounced cell proliferation, while 
in vivo all implants were found to promote new bone forma-
tion. So far, additive manufacturing techniques can create con-
trollable macro- and micropores, however, their resolution is in 
general not high enough to control nanotopographical features, 
including nanopores.[120]
2.2. Mechanical Properties
Various studies have demonstrated that the mechanical proper-
ties of the substrate the cells are in contact with, affect cell fate. 
For example, substrate stiffness has been shown to affect MSCs 
attachment, proliferation and osteogenic differentiation.[121] 
Furthermore, it has been demonstrated that stiffness-medi-
ated focal adhesion kinase (FAK) is essential for the onset of 
osteogenesis.[122,123] Although these studies have demonstrated 
that substrate stiffness may affect cell behavior, they were per-
formed on polymeric materials, the stiffness of which is gen-
erally several orders of magnitude lower than that of CaPs. In 
ceramic substrates, it is not possible to modify the mechanical 
properties without changing other properties, including chem-
ical composition and porosity, which are both known to also 
play also an important role in regulating cell fate, and conse-
quently, the cell and tissue response to the material. Therefore, 
decoupling mechanical from other properties is challenging. 
In a recent elegant study, Mattei et al. suggested a strategy to 
decouple the effect of the mechanical properties from other 
material-related cues in HA.[25] Composite HA/gelatin hydrogel 
constructs were produced with varying weight ratios of the two 
components, and in parallel HA-free scaffolds were produced 
with different amounts of glutaraldehyde (GTA), a crosslinking 
agent (Figure 4). The variations in the stiffness of the HA/
gelatin constructs due to differences in the HA content were 
matched in the HA-free constructs by varying the GTA content, 
thus achieving HA-free mechanical equivalents of the HA/
gelatin constructs with similar surface roughness. Human peri-
osteal derived progenitor cells (PDPCs) were cultured on the 
different materials, and the BMP2, Runx2 and BGLAP mRNA 
levels were measured after one week to investigate the differ-
entiation of the cells towards the osteogenic phenotype. The 
results indicated that the extent of osteogenic differentiation 
was dependent on the HA content in HA/gelatin constructs, 
and on the stiffness of the HA-free scaffolds, suggesting that 
the instructive signals for these markers may have their origins 
in the substrate stiffness.
Adv. Healthcare Mater. 2017, 6, 1601478
Figure 4. Strategy to elucidate the role of stiffness in CaP bioac-
tivity suggested by Mattei et al.[25] Gelatin scaffolds were loaded with 
hydroxyapatite (1), which increased their stiffness, while a range of 
mechanical equivalents in HA-free gelatin (2) were produced by changing 
the extent of crosslinking.
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To the best of our knowledge, there are no other studies that 
specifically focused on decoupling the mechanical from other 
properties in CaPs. Nevertheless, the work by Mattei et al. may 
be a basis for combining this strategy with others, such as the 
one developed by us,[52] achieving further control over the indi-
vidual material properties.
2.3. Surface Energy, Wettability and Polarization
A number of studies have reported changes in cell behavior 
due to variations in surface energy or wettability. Although both 
physical parameters are related, with higher surface energy 
causing an increase in the contact angle, the former is an 
intrinsic property of the material, while the latter is also affected 
by the surface-structural properties, including roughness.[124] 
The polarization of a material surface leads to an increase in 
wettability, and both surface energy and wettability are impor-
tant for the adsorption of molecules, including proteins, on the 
material surface,[19,125] which is the first event occurring upon 
contact between the material and a biological environment. 
This initial adsorption of the proteins is largely determinant 
for cell attachment on the material.[126] In general, it has been 
reported that surfaces with high surface energy promote cell 
adhesion.[18,124] Several techniques exist that allow to change 
the surface energy or the wettability of the materials: deposition 
of self-assembled monolayers, application of electromagnetic 
fields, electrochemical methods, changes in the environmental 
conditions, changes in temperature or pH, application of sur-
face pressure or low-electron energy irradiation,[127] although 
they have not been extensively applied to CaP biomaterials. 
The use of any of these techniques implies a change in the 
surface chemistry of the material, as both surface energy and 
surface chemistry are intertwined properties.
3. Role of Chemistry
The success of CaPs as bone graft substitutes has been tradi-
tionally attributed to the similarity of their chemical composi-
tion with that of bone mineral.[128] During the degradation 
process it has been shown that at the surface of CaPs, a 
dynamic process occurs whereby calcium and inorganic phos-
phate ions are released, and, upon reaching supersaturation, 
reprecipitated in the form of a carbonated apatite layer, along 
with coprecipitation of organic compounds, such as proteins, 
from the surrounding body fluids.[129] The reality of the degra-
dation of CaPs in vivo, is however, more complex. Three main 
routes of degradation of CaPs are identified; physico-chemical 
dissolution as a result of hydrolysis of the surface, cellular deg-
radation by mineral-resorbing cells and mechanical degrada-
tion. Each of these processes is dependent on the properties of 
the ceramic, as well as on the (micro)environmental conditions, 
and each process affects (the extent of) the other two.[129]
Different phase composition is associated with different 
surface reactivity and dissolution kinetics. Differences in the 
biological performance in accordance with the different phase 
compositions of the materials have been reported,[22] and, for 
example, BCP is considered to have a higher osteoinductive 
potential than HA.[130] Besides the differences in reactivity 
and dissolution kinetics, the differences in crystal structures 
may lead to a different surface energy,[124] a factor that can also 
change the biological performance of CaPs.
Previous studies have demonstrated that both calcium and 
inorganic phosphate ions have an effect on skeletal cells.[50,131] 
The presence of calcium in the cell culture medium has been 
shown to have a stimulatory effect on osteoblast proliferation 
and differentiation and to induce a number of intracellular 
signaling pathways through the activation of calcium receptors 
related to the regulation of osteoblasts and osteoclasts.[131,132] 
High levels of inorganic orthophosphate were shown to induce 
osteoblasts apoptosis in vitro,[50,133] while low levels have been 
related to an increase in both osteoclastic resorptive activity and 
osteoblast differentiation.[134]
CaPs admit the substitution of (a portion of) calcium and 
phosphate ions in the crystal lattice by other ions with thera-
peutic potential, usually called bioinorganics.[50] For example, 
magnesium can completely replace calcium, thus producing 
magnesium phosphate, or ceramics having different ratios 
of calcium and magnesium.[135] Other bioinorganics that can 
be incorporated into CaPs or combined with them are, for 
example, strontium,[136,137] silicate,[138] cobalt,[139] fluoride, 
carbonate, copper or zinc.[137,140] It should however be noted 
that by substituting a calcium, phosphate, or, in the case of 
hydroxyapatite a hydroxide ion by a guest ion, one not only 
changes the chemical composition of the ceramic, but it also 
modifies many other physico-chemical properties, including 
its crystallinity, mechanical or degradation properties.[50,137,141] 
Consequently, when investigating the behavior of cells or tis-
sues on such a ceramic, it is difficult to attribute an effect solely 
to the change in chemistry, i.e. addition of a new ion.
Another difficulty in identifying the cause of a biological 
response arises from the degradation of the ceramic in a bio-
logical environment, whereby not only the guest ion, but also 
the host ceramic ions are released, in different amounts.[142]
Due to the issues discussed above, strategies are needed 
to isolate the role of the different ions that may be present in 
CaPs, and to evaluate how important the chemistry is in relation 
with other factors, such as the topography or the mechanical 
properties.
3.1. Incorporation of Calcium and Phosphate Ions into  
Polymeric Delivery Systems
The individual influence of the calcium and phosphate ions 
on cell and tissue behavior is difficult to elucidate in CaPs, 
because their release and uptake generally occur simultane-
ously. Furthermore, the effects of other ions present in the lat-
tice, and other physico-chemical factors, cannot be excluded. To 
overcome this issue, the incorporation of salts containing only 
calcium or only phosphate into polymeric carriers has been 
explored as a way to exclude the effects of other parameters. 
While such a system provides advantages of having a func-
tional material, that allows cell culture on the surface and study 
of a single ion, obviously, the system is not ideal, as it intro-
duces a new material, i.e. the polymer, with its own chemistry, 
mechanical properties, etc. The attention should therefore be 
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paid to the choice of the polymer in terms of properties that 
could affect the experiment.
An example of study in which the above described strategy 
was applied is based on the findings suggesting that inor-
ganic pyrophosphate (PPi) prevents the mineralization of type 
I collagen by binding to the CaP crystals.[143] ALP-mediated 
hydrolysis of PPi increases the local concentration of inorganic 
orthophosphate (Pi), promoting collagen mineralization by 
overcoming the inhibitory effect of PPi.[144,145] In an attempt to 
mimic this process by employing synthetic materials, we have 
developed constructs consisting of polycaprolactone (PCL), 
into which mildly acidic and alkaline sodium phosphate pow-
ders, and the pH-neutral mixture of the two were added.[146] 
15-day ectopic implantation of the constructs in the thoracic 
muscles of CD1 mice resulted in ectopic mineral formation 
following release of sodium phosphate, indeed suggesting 
that an increase in local saturation of soft tissue with inor-
ganic orthophosphate induced collagen mineralization, even in 
absence of additional calcium.
Danoux et al. incorporated, in separated experiments, cal-
cium ions (as calcium carbonate salt) or phosphate ions (as 
sodium phosphate salt) into a polylactic acid (PLA) matrix and 
tested the individual effects of the ions on growth and differ-
entiation of bone marrow-derived hMSCs.[59] The results of 
this study indicated that calcium ions stimulated cell prolif-
eration and differentiation into the osteogenic lineage in a 
dose-dependent manner, which was in accordance with a pre-
vious study, in which the cells were cultured in media with 
increased calcium concentrations.[147] Similarly, the effect of 
the phosphate concentration on cell proliferation was dose-
dependent: cell proliferation was stimulated between 2 and 
4 mM, but inhibited beyond 5 mM, a fact that was attributed 
to the induction of cell apoptosis.[133] The osteogenic differen-
tiation, in particular the expression of BMP2 and OP, was sig-
nificantly increased in cells cultured on materials containing 
inorganic phosphate, which was also in accordance with pre-
vious work.[148] Interestingly, the measurements of the calcium 
ion concentrations of the cell culture medium containing PLA-
calcium composite were equal to or lower than of medium con-
taining control PLA samples or PLA-phosphate samples, which 
may suggest the formation of a new CaP layer on the surface of 
the composites, and/or the mineralization of the extracellular 
matrix produced by the hMSCs. This again emphasizes the 
importance of the biological environment in which the material 
is tested (i.e. cell culture medium contains calcium and phos-
phate ions itself as well as serum proteins), which interacts 
with the material, even in the absence of cells. It would there-
fore be important to invest in new analytical tools that allow 
for spatiotemporal chemical and other analyses within a (in 
vitro) biological system. As an example, recently, a study dem-
onstrated the use of time-of-flight secondary ion mass spectros-
copy to measure uptake of strontium ions released from CaP 
cement by osteoclasts.[149] This and similar techniques, based 
on mass spectrometry imaging, for example, are highly prom-
ising to further unravel the physico-chemical processes occur-
ring at the interface of biomaterials and cells or tissues.
Within the context of delivery and study of individual ions, 
one could also consider delivery systems as used for biologics, 
such as growth factors. For example, biodegradable PLA-based 
microspheres have the advantage of providing a sustainable 
release of drugs encapsulated inside them,[150] while the carrier 
is degraded into lactic acid, which is finally transformed into 
carbon dioxide and water in biological systems.[142,151] Recently, 
we took advantage of these properties to design a calcium 
delivery system by incorporating a calcium chloride salt into 
PLA microspheres without affecting their surface morphology, 
and to release calcium ions upon immersion of the micro-
spheres in cell culture media.[142] While in this proof-of-concept 
study, no significant effect of calcium-containing microspheres 
was observed on proliferation and osteogenic differentiation of 
hMSCs in a transwell in vitro set-up (Figure 5.1), the system 
may be valuable for screening the effects of individual ions in 
various biological conditions, before designing new functional 
biomaterials, for example for bone regeneration.
While this strategy provides an excellent way for assessing 
the individual role of the different ions present in CaPs, a 
criticism can be raised that all possible synergies between the 
chemistry and other physical properties are completely lost, as 
well as the possible synergies between different ions. A bottom-
up approach could be a possible solution, starting by assessing 
the role of the individual ions, then the role of the combina-
tions of the selected ions embedded in a polymer construct, 
and finally shaping the polymer such that it resembles the sur-
face topography, or even approximates the mechanical proper-
ties of a CaP.
3.2. Coating Techniques
The role of surface chemistry can also be elucidated by depos-
iting a thin layer of CaP on the surface of another material 
(Figure 5.2), using for example electrodeposition[152] or bio-
mimetic techniques.[43,153] This method is also often used to 
improve the bioactivity of inert materials, such as titanium, 
in a bony environment. Alternatively, depositing a thin layer 
of another material on the surface of CaP may potentially be 
a suitable method for retaining the surface structure of the 
ceramic, while changing the surface chemistry.
For example, in our in vivo studies,[154,155] it was shown that 
a thin (20–60 micrometers) octacalcium phosphate coating 
produced using a biomimetic technique, was able to render 
the otherwise bioinert porous titanium alloy (Ti6Al4V), oste-
oinductive.[156] Although it is plausible that this change of sur-
face chemistry is responsible for the observed effect, it is worth 
mentioning that the highly crystalline OCP coating also modi-
fied the surface roughness of the metal.
In a paper that was discussed in the topography section, 
Danoux et al. coated a structural polymer replica of a CaP with 
a thin amorphous layer of CaP, using a biomimetic precipita-
tion method to reintroduce the chemistry of the ceramic.[52] 
The results of this study confirmed that the effect of the sur-
face chemistry, i.e. presence of CaP, on the osteogenic differen-
tiation of hMSCs was more pronounced than the effect of the 
(surface) geometrical features.
Burke et al. used photolithography to produce a silicon 
substrate with well-defined surface microstructure, followed 
by a chemical etching process and deposition of a thin CaP 
coating by radio frequency magnetron deposition.[157] In order 
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to increase the crystallinity of this thin CaP layer, a post-dep-
osition thermal annealing process was used. The extensive 
characterization confirmed the deposition of a phase-pure HA 
coating, that was relatively stable in cell culture medium over 
a period of 10 days. The culture of SaOS-2 osteoblasts on the 
coated surface showed an increase of the markers of osteogenic 
differentiation, ALP, BMP4 and collagen type I as compared to 
uncoated surfaces.
Similarly, Hu et al. used a hydrothermal process to coat sand-
blasted and acid etched titanium disks with nano-HA.[158] XRD 
and FTIR were used to confirm that the coating was made of 
crystalline HA. MC3T3-E1 cells were cultured on the materials, 
and it was shown that the HA coating significantly improved 
the cell attachment after 4 h and increased the ALP after pro-
longed culture time.
In a recent study, van Oirschot et al. evaluated the osteophi-
licity of a range of titanium substrates with different surface 
modifications, namely machined, grit-blasted and grit-blasted/
acid-etched, and, in the case of grit-blasted titanium surfaces, 
coated with CaP using different techniques, namely pulsed 
laser deposition (PLD), plasma-spraying, electrospray deposi-
tion (ESD), biomimetic coating and magnetron sputtering.[159] 
A thorough physico-chemical and structural characterization 
showed that differences existed both in chemistry and surface 
roughness among the different materials. Bone conduction-
cassettes containing the materials were attached on the goat 
transverse processes for a comparative in vivo analysis of the 
bone deposition on the surfaces of the materials over a period 
of twelve weeks. The results of the histomorphometrical anal-
yses showed that predominantly plasma-sprayed coatings had 
a positive effect on the osteophilicity, plausibly due to a higher 
surface roughness as compared to other materials, or due to 
the existence of amorphous CaP regions in the coating, that 
may release calcium ions, subsequently stimulating the pro-
cess of bone formation. While this study exemplifies an elegant 
attempt to investigate the role of CaPs versus titanium surface, 
and the role of surface structure, providing conclusive evidence 
regarding the effect of individual properties remains chal-
lenging, considering the differences in the chemical composi-
tion among the coatings.
The coating strategy constitutes an excellent method to 
decouple the role of surface chemistry from the rest of the prop-
erties, which remain almost intact. The thin layer of CaP may 
affect the surface roughness of the material, but depending on 
the coating method this effect can be almost negligible.
3.3. Reducing Surface-Structural Features
A more basic approach to reduce the influence of the topog-
raphy when studying that of surface chemistry is to actually 
reduce the size of the topographical features present on the sur-
face of the material. This approach can be combined with the 
coating procedures described in the previous section.
To test the hypothesis that the microstructure of CaP 
ceramics is important for the osteoinductive capacity of CaP 
ceramics, Davison et al. generated BCP discs having different 
surface microstructural feature dimensions.[44] Upon sintering 
at 1150 °C, the discs were coated with a 50 nm-thick film of 
titanium using magnetron sputtering following a previously 
established procedure,[160] to “cover” CaP on the surface, thus 
decoupling the chemical from the topographical effect. After 
intramuscular implantation in dogs for 12 weeks, both the 
BCP disc with small microstructural features and the respective 
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Figure 5. Strategies to elucidate the role of the chemistry in CaP bioactivity. 1) Incorporation of calcium ions into polymeric microspheres to study 
the effect of the ions on cell behavior using a transwell cell culture system. Reproduced with permission.[142] Copyright 2014, Russian Academy of 
Sciences. 2) Different methods for producing thin CaP coatings: a) electrodeposition setup for CaP deposition on titanium discs, consisting of a two-
electrode (Pt and Ti) cell configuration immersed in a supersaturated solution containing calcium and phosphate ions. Adapted with permission.[152] 
2006, Springer. B) Biomimetic deposition of CaP from a supersaturated simulated body fluid. Adapted with permission.[153] 2006, The Royal Society.
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Ti-coated BCP disc were able to promote the formation of oste-
oclast-like cells and to induce de novo bone formation, but the 
size of the osteoclast formed on the Ti-coated BCP discs was 
between two and four times smaller than the size of osteoclasts 
formed on non-coated BCP discs. It should be noted that the 
titanium coating was not fully homogenous to completely “seal” 
the surface, still allowing the ions exchange between the under-
lying ceramic and the biological environment. Nevertheless, 
the results of this paper suggested that the size of the surface 
topography features plays an important role in osteoinduction.
In a recent study, Park et al. combined two of the previously 
described strategies, namely the coating techniques and the 
reduction of the structural features.[161] By coating flat β-TCP 
discs with HA, Mg and both HA and Mg, they studied the 
effect of the surface chemistry on osteoconductive properties 
of β-TCP ceramic. The HA coating was deposited using radio 
frequency magnetron sputtering, the Mg coating by DC sput-
tering, and the HA/Mg by the combination of the two sput-
tering techniques. SEM imaging and EDX analyses confirmed 
that the microstructure of the HA-coated β-TCP was very sim-
ilar to that of β-TCP, while the surfaces of Mg-coated β-TCP 
and MgHA-coated β-TCP were similar to one other, but dif-
ferent from that of the uncoated β-TCP and HA-coated β-TCP. 
Osteoblastic MC3T3-E1 cell line culture indicated that cell mor-
phology was shown to change from round or spindle-like on 
uncoated β-TCP to more polygonal shaped on the coated discs. 
While cell proliferation, evaluated using the MTT assay, was 
similar for all materials, the ALP activity, a marker for osteo-
genic differentiation, was higher on the HA-coated β-TCP and 
Mg-coated β-TCP, and significantly higher on the MgHA-coated 
β-TCP, showing the potential benefit of this method to modify 
the biological performance of the ceramic.
The method of reducing or eliminating microstructural fea-
tures can be useful for evaluating the independent role of the 
chemistry. Nevertheless, it remains questionable whether with 
the currently available techniques, the topographical effect can 
indeed be fully eliminated, in particular considering that sev-
eral studies have shown that cells may be responsive to struc-
tural features at the nanoscale,[162–164] even as small as a few 
nanometers in size.[164,165] Moreover, the use of this strategy to 
test CaP coatings with different ion substitutions is still chal-
lenging, as the incorporation of the ions can change the surface 
morphology of the coatings.[166]
4. Conclusions and Outlook
This progress report focused on discussing strategies to elu-
cidate how individual properties of CaPs affect cell and tissue 
response to the material. In our view, this knowledge is 
essential for the development of new bone graft substitutes 
with improved bone regenerative potential. Indeed, in order 
to develop synthetic bone graft substitutes that can actually 
replace natural grafts in all, or at least the majority of clinical 
application, a design-driven approach is needed, in contrast to 
the processing-driven approaches, which are commonly used 
nowadays. The overview of different strategies described here 
has shown that a number of, often contradictory, results exist 
regarding the importance of a certain property in the biological 
response. Three main reasons can be defined for these contra-
dictions: (1) an inadequate or incomplete material characteriza-
tion, (2) a wide variety of methods used to assess the biological 
performance, along with the unavoidable inter- and intra-spe-
cies variations, in particular in in vivo studies and (3) the fact 
that the material properties of CaPs are largely intertwined and 
cannot be independently tuned.
The importance of a comprehensive material characteriza-
tion, including all those parameters that have been reported in 
the literature, or suspected to affect cell behavior, is crucial for 
achieving a full understanding of the mechanisms of action 
of CaPs. Only by fully understanding the materials and their 
properties, it will be possible to describe why and how these 
properties affect the biological performance. An adequate and 
complete characterization is also critical to evaluate the efficiency 
of the strategies developed to decouple individual properties, and 
to avoid claims that are based on selective observations.
The development of strategies to decouple the role of indi-
vidual properties of CaPs in the biological performance of the 
materials has been put forward as a necessity for the field of 
biomaterials where the demand for efficient and affordable 
treatments for damaged and diseased organs and tissues is 
growing, and where the conventional methods of developing 
new biomaterials may fall short. However, the use of these 
strategies can also be heavily criticized, as they are not flaw-
less yet, and furthermore, possible synergies among different 
material properties may be lost. Therefore, decoupling strate-
gies should be seen as a first step toward the design of new 
materials for healthcare applications. The obvious next step will 
be to combine the desired properties in an intelligent manner, 
an effort that is not trivial and may require the development of 
new technologies. On a positive note, there is much room for 
creativity in the years to come in a field that has already made a 
big difference to the quality of patients’ lives.
Conflict of Interest
The authors declare no conflict of interest.
Acknowledgements
This research has been made possible with the support of the Dutch 
Province of Limburg.
Keywords
biomaterials-biological systems interactions, biomaterials design, bone 
graft substitutes, calcium phosphates, property-function relationships
Received: December 30, 2016
Revised: March 24, 2017
Published online: May 23, 2017
[1] M. Bohner, L. Galea, N. Doebelin, J. Eur. Ceram. Soc. 2012, 32, 
2663.
[2] V. Uskokovic, V. M. Wu, Materials (Basel) 2016, 9, 434.
Adv. Healthcare Mater. 2017, 6, 1601478
1601478 (13 of 15)
www.advancedsciencenews.com www.advhealthmat.de
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
[3] T. A. Russell, R. K. Leighton, J. Bone Joint. Surg. Am. 2008, 90, 
2057.
[4] H. Yuan, H. Fernandes, P. Habibovic, J. de Boer, A. M. C. Barradas, 
A. de Ruiter, W. R. Walsh, C. a. van Blitterswijk, J. D. de Bruijn, 
Proc. Natl. Acad. Sci. USA 2010, 107, 13614.
[5] D. F. Williams, The Williams Dictionary of Biomaterials, Liverpool 
University Press, UK,  1999.
[6] J. Zhang, X. Luo, D. Barbieri, A. M. Barradas, J. D. de Bruijn, 
C. A. van Blitterswijk, H. Yuan, Acta Biomateralia 2014, 10, 3254.
[7] J. Costa-Rodrigues, A. Fernandes, M. A. Lopes, M. H. Fernandes, 
Acta Biomateralia 2012, 8, 1137.
[8] D. D. Deligianni, N. D. Katsala, P. G. Koutsoukos, Y. F. Missirlis, 
Biomaterials 2001, 22, 87.
[9] M. J. Coathup, Q. Cai, C. Campion, T. Buckland, G. W. Blunn, 
J. Biomed. Mater. Res., Part B 2013, 101, 902.
[10] V. Uskokovic, S. S. Batarni, J. Schweicher, A. King, T. A. Desai, 
ACS Appl. Mater. Interfaces 2013, 5, 2422.
[11] Z. Xu, C. Liu, J. Wei, J. Sun, J. Appl. Toxicol. 2012, 32, 429.
[12] Z. Shi, X. Huang, Y. Cai, R. Tang, D. Yang, Acta Biomateralia 2009, 
5, 338.
[13] L. Wang, D. Barbieri, H. Zhou, J. D. de Bruijn, C. Bao, H. Yuan, 
J. Biomed. Mater. Res., Part A 2015, 103, 1919.
[14] C. Danoux, D. Pereira, N. Döbelin, C. Stähli, J. Barralet, 
C. v. Blitterswijk, P. Habibovic, Adv. Healthcare Mater. 2016, 5, 1775.
[15] S. Dasgupta, S. Tarafder, A. Bandyopadhyay, S. Bose, Mater. Sci. 
Eng.,Part C 2013, 33, 2846.
[16] D. Veljovic, M. Colic, V. Kojic, G. Bogdanovic, Z. Kojic, A. Banjac, 
E. Palcevskis, R. Petrovic, D. Janackovic, J. Biomed. Mater. Res., 
Part A 2012, 100, 3059.
[17] H. Lapczyna, L. Galea, S. Wüst, M. Bohner, S. Jerban, A. Sweedy, 
N. Doebelin, N. van Garderen, S. Hofmann, G. Baroud, R. Müller, 
B. von Rechenberg, Eur. Cells Mater. 2014, 28, 299.
[18] M. Nakamura, N. Hori, H. Ando, S. Namba, T. Toyama, 
N. Nishimiya, K. Yamashita, Mater. Sci. Eng., Part C 2016, 62, 283.
[19] E. A. Dos Santos, M. Farina, G. A. Soares, K. Anselme, J. Mater. 
Sci.: Mater. Med. 2008, 19, 2307.
[20] E. S. Thian, Z. Ahmad, J. Huang, M. J. Edirisinghe, S. N. Jayasinghe, 
D. C. Ireland, R. A. Brooks, N. Rushton, W. Bonfield, S. M. Best, 
Acta Biomateralia 2010, 6, 750.
[21] P. Kasten, I. Beyen, P. Niemeyer, R. Luginbuhl, M. Bohner, 
W. Richter, Acta Biomateralia 2008, 4, 1904.
[22] J. D. d. Bruijn, C. A. v. Blitterswijk, J. E. Davies, Cells&Materials 
1993, 3, 407.
[23] W. Xue, X. Liu, X. Zheng, C. Ding, J. Biomed. Mater. Res., Part A 
2005, 74, 553.
[24] W. H. Lee, A. V. Zavgorodniy, C. Y. Loo, R. Rohanizadeh, J. Biomed. 
Mater. Res., Part A 2012, 100, 1539.
[25] G. Mattei, C. Ferretti, A. Tirella, A. Ahluwalia, M. Mattioli-Belmonte, 
Sci. Rep. 2015, 5, 10778.
[26] D. P. Burke, H. Khayyeri, D. J. Kelly, Biomech. Model. Mechanobiol. 
2015, 14, 93.
[27] M. Witkowska-Zimny, K. Walenko, E. Wrobel, P. Mrowka, 
A. Mikulska, J. Przybylski, Cell. Biol. Int. 2013, 37, 608.
[28] H. T. Shiu, B. Goss, C. Lutton, R. Crawford, Y. Xiao, Tissue Eng., 
Part B 2014, 20, 697.
[29] N. Laurens, P. Koolwijk, M. P. M. d. Maat, J. Thromb. Haemostasis 
2006, 4, 932.
[30] P. Moreo, J. M. García-Aznar, M. Doblaré, J. Theor. Biol. 2009, 
260, 1.
[31] L. Kikuchi, J. Y. Park, C. Victor, J. E. Davies, Biomaterials 2005, 26, 
5285.
[32] Z. Sheikh, M.-N. Abdallah, A. Hanafi, S. Misbahuddin, H. Rashid, 
M. Glogauer, Materials 2015, 8, 7913.
[33] F. Velard, J. Braux, J. Amedee, P. Laquerriere, Acta Biomateralia 
2013, 9, 4956.
[34] G. Hosgood, Veterinary Surgical 1993, 22, 490.
[35] T. F. Deuel, R. M. Senior, D. Chang, G. L. Griffin, R. L. Heinrikson, 
E. T. Kaiser, Proc. Natl. Acad. Sci. USA 1981, 78, 4584.
[36] R. Dimitriou, E. Tsiridis, P. V. Giannoudis, Injury 2005, 36, 1392.
[37] L. R. Kark, J. M. Karp, J. E. Davies, Clin. Oral Implants Res. 2006, 
17, 321.
[38] Z. Sheikh, P. Brooks, O. Barzilay, N. Fine, M. Glogauer, Materials 
2015, 8, 5671.
[39] B. R. Constantz, B. M. Barr, I. C. Ison, M. T. Fulmer, J. Baker, 
L. McKinney, S. B. Goodman, S. Gunasekaren, D. C. Delaney, 
J. Ross, R. D. Poser, J. Biomed. Mater. Res. 1998, 43, 451.
[40] C. Graneli, A. Thorfve, U. Ruetschi, H. Brisby, P. Thomsen, 
A. Lindahl, C. Karlsson, Stem Cell Res. 2014, 12, 153.
[41] D. R. Villareal, A. Sogal, J. L. Ong, J. Oral Implantol. 1998, 24, 67.
[42] W. H. Lee, C. Y. Loo, R. Rohanizadeh, Colloids Surf., B 2014, 122, 
823.
[43] D. O. Costa, P. D. Prowse, T. Chrones, S. M. Sims, D. W. Hamilton, 
A. S. Rizkalla, S. J. Dixon, Biomaterials 2013, 34, 7215.
[44] N. L. Davison, J. Su, H. Yuan, J. J. J. P. v. d. Beucken, J. D. de Bruijn, 
F. Barrère-de Groot, Eur. Cells Mater. 2015, 29, 314.
[45] Y. Yamada, A. Ito, H. Kojima, M. Sakane, S. Miyakawa, T. Uemura, 
R. Z. LeGeros, J. Biomed. Mater. Res., Part A 2008, 84, 344.
[46] N. L. Davison, B. ten Harkel, T. Schoenmaker, X. Luo, H. Yuan, 
V. Everts, F. Barrere-de Groot, J. D. de Bruijn, Biomaterials 2014, 
35, 7441.
[47] A. Barradas, H. Yuan, C. v. Blitterswijk, P. Habibovic, Eur. Cells 
Mater. 2011, 21, 407.
[48] A. M. Barradas, H. Yuan, J. van der Stok, B. Le Quang, H. Fernandes, 
A. Chaterjea, M. C. Hogenes, K. Shultz, L. R. Donahue, 
C. van Blitterswijk, J. de Boer, Biomaterials 2012, 33, 5696.
[49] K. Lin, C. Wu, J. Chang, Acta Biomateralia 2014, 10, 4071.
[50] P. Habibovic, J. E. Barralet, Acta Biomateralia 2011, 7, 3013.
[51] R. Z. LeGeros, D. Mijares, F. Yao, J. P. LeGeros, T. Bromage, V. La, 
Q. Xi, S. Tannous, R. Kijkowska, Key Eng. Mater. 2006, 309–311, 
697.
[52] C. Danoux, L. Sun, G. Kocer, Z. T. Birgani, D. Barata, J. Barralet, 
C. A. van Blitterswijk, R. Truckenmuller, P. Habibovic, Adv. Mater. 
2016, 28, 1803.
[53] E. C. Pegg, F. Matboli, T. Marriott, I. Khan, C. A. Scotchford, 
J. Biomater. Appl. 2014, 28, 946.
[54] K. Anselme, M. Bigerelle, J. Mater. Sci.: Mater. Med. 2006, 17, 471.
[55] E. A. dos Santos, M. Farina, G. A. Soares, K. Anselme, J. Biomed. 
Mater. Res., Part A 2009, 89, 510.
[56] S. A. Hacking, M. Tanzer, E. J. Harvey, J. J. Krygier, J. D. Bobyn, 
Clin. Orthop. Rel. Res. 2002, 405, 24.
[57] E. Engel, S. Del Valle, C. Aparicio, G. Altankov, L. Asin, J. A. Planell, 
M. P. Ginebra, Tissue Eng., Part A 2008, 14, 1341.
[58] M. Bohner, Y. Loosli, G. Baroud, D. Lacroix, Acta Biomateralia 
2011, 7, 478.
[59] C. B. Danoux, D. C. Bassett, Z. Othman, A. I. Rodrigues, R. L. Reis, 
J. E. Barralet, C. A. van Blitterswijk, P. Habibovic, Acta Biomateralia 
2015, 17, 1.
[60] K. Anselme, M. Bigerelle, A. Ponche, Proceedings of the Institution 
of Mechanical Engineers, Part H: Journal of Engineering in Medicine 
2010, 224, 1471.
[61] A. Wennerberg, T. Albrektsson, Acta Odontol. Scand. 2009, 67, 
333.
[62] U. Meyer, a. Büchter, H. P. Wiesmann, U. Joos, D. B. Jones, 
Eur. Cells Mater. 2005, 9, 39.
[63] A. L. Rosa, M. M. Beloti, R. Van Noort, Dental Mater. 2003, 19, 
768.
[64] F. Faghihi, M. Baghaban, Biomed. Pap. Med. Fac. Univ. Palacky 
Olomouc Czech. Repub. 2014, 158, 5.
[65] M. L. Schwarz, M. Kowarsch, S. Rose, K. Becker, T. Lenz, L. Jani, 
J. Biomed. Mater. Res., Part A 2009, 89, 667.
Adv. Healthcare Mater. 2017, 6, 1601478
1601478 (14 of 15)
www.advancedsciencenews.com www.advhealthmat.de
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
[66] S. Samavedi, A. R. Whittington, A. S. Goldstein, Acta Biomateralia 
2013, 9, 8037.
[67] T. J. Webster, C. Ergun, R. H. Doremus, R. W. Siegel, R. Bizios, 
J. Biomed. Mater. Res. 2000, 51, 475.
[68] G. B. Reddy, S. L. Hyzy, Z. Schwartz, B. D. Boyan, Acta Biomaterialia 
2016, 31, 425.
[69] V. Karageorgiou, D. Kaplan, Biomaterials 2005, 26, 5474.
[70] H. Yuan, K. Kurashina, J. D. d. Bruijn, Y. Li, K. d. Groot, X. Zhang, 
Biomaterials 1999, 20, 1799.
[71] G. Daculsi, R. Legeros, M. Heughebaert, Calcif. Tissue Int. 1990, 
46, 20.
[72] J. X. Lu, B. Flautre, K. Anselme, P. Hardouin, A. Gallur, 
M. Descamps, B. Thierry, J. Mater. Sci.: Mater. Med.Medicine 1999, 
10, 110.
[73] O. Chan, M. J. Coathup, A. Nesbitt, C. Y. Ho, K. A. Hing, 
T. Buckland, C. Campion, G. W. Blunn, Acta Biomaterialia 2012, 8, 
2788.
[74] S. F. Hulbert, F. A. Young, R. S. Mathews, J. J. Klawitter, C. D. Talbert, 
F. H. Stelling, J. Biomed. Mater. Res. 1970, 4, 433.
[75] Y. Kuboki, H. Takita, D. Kobayashi, E. Tsuruga, M. Inoue, 
M. Murata, N. Nagai, Y. Dohi, H. Ohgushi, J. Biomed. Mater. Res. 
1998, 39, 190.
[76] F. M. Klenke, Y. Liu, H. Yuan, E. B. Hunziker, K. A. Siebenrock, 
W. Hofstetter, J. Biomed. Mater. Res., Part A 2008, 85, 777.
[77] C. L. Camire, U. Gbureck, W. Hirsiger, M. Bohner, Biomaterials 
2005, 26, 2787.
[78] W. Xue, S. Tao, X. Liu, X. Zheng, C. Ding, Biomaterials 2004, 25, 
415.
[79] P. J. t. Brugge, J. G. C. Wolke, J. A. Jansen, Clin. Oral. Impl. Res. 
2003, 14, 472.
[80] P. Frayssinet, F. Tourenne, N. Rouquet, P. Conte, C. Delga, 
G. Bonel, J. Mater. Sci.: Mater. Med. 1994, 5, 11.
[81] S. H. Maxian, T. d. Stefano, M. C. Melican, M. L. Tiku, 
J. P. Zawadsky, J. Biomed. Mater. Res. 1998, 40, 171.
[82] P. J. ter Brugge, J. G. Wolke, J. A. Jansen, J. Biomed. Mater. Res. 
2002, 60, 70.
[83] D. E. MacDonald, F. Betts, M. Stranick, S. Doty, A. L. Boskey, 
J. Biomed. Mater. Res. 2001, 54, 480.
[84] J. D. d. Bruijn, Y. P. Bovell, C. A. v. Blitterswijk, Biomaterials 1994, 
15, 543.
[85] C. A. v. Blitterswijk, H. Leenders, J. v. d. Brink, Y. P. Bovell, 
J. S. Flach, J. D. d. Bruijn, K. d. Groot, Trans. 16th Ann. Meeting 
Soc. Biomaterials 1993, 337.
[86] M. Bigerelle, A. Ponche, K. Anselme, Proceedings of the Institution 
of Mechanical Engineers, Part H: Journal of Engineering in Medicine 
2010, 224, 1487.
[87] S. Dobbenga, L. Fratila-Apachitei, A. A. Zadpoor, Acta Biomaterialia 
2016, 46, 3.
[88] P. Locci, E. Becchetti, M. Pugliese, L. Rossi, C. Lilli, M. Calvitti, 
N. Staffolani, J. Periodontol. 1996, 67, 1260.
[89] A. P. Tomsia, J. S. Moya, F. Guitian, Scr. Metall. Mater. 1994, 31, 
995.
[90] D. D. Hass, Y. Marciano, H. N. G. Wadley, Surf. Coat. Technol. 
2004, 185, 283.
[91] L. E. Macaskie, P. Yong, M. Paterson-Beedle, A. C. Thackray, 
P. M. Marquis, R. L. Sammons, K. P. Nott, L. D. Hall, J. Biotechnol. 
2005, 118, 187.
[92] F. Barrére, C. M. van der Valk, R. A. J. Dalmeijer, G. Meijer, 
C. A. van Blitterswijk, K. de Groot, P. Layrolle, J. Biomed. Mater. 
Res., Part A 2002, 66, 779.
[93] K. L. Choy, Prog. Mater. Sci. 2003, 48, 57.
[94] M. Kumar, H. Dasarathy, C. Riley, J. Biomed. Mater. Res., Part A 
1999, 45, 302.
[95] M. L. Cairns, B. J. Meenan, G. A. Burke, A. R. Boyd, Colloids Surf., 
B 2010, 78, 283.
[96] E. C. Pegg, F. Matboli, T. Marriott, I. Khan, C. a. Scotchford, 
J. Biomater. Appl. 2014, 28, 946.
[97] B. Flatøy, S. M. Röhrl, B. Bøe, L. Nordsletten, Acta Orthopaedica 
2016, 87, 42.
[98] M. Wieland, B. Chehroudi, M. Textor, D. M. Brunette, J. Biomed. 
Mater. Res. 2002, 60, 434.
[99] M. Schuler, T. P. Kunzler, M. de Wild, C. M. Sprecher, D. Trentin, 
D. M. Brunette, M. Textor, S. G. Tosatti, J. Biomed. Mater. Res., Part 
A 2009, 88, 12.
[100] L. Sun, C. B. Danoux, Q. Wang, D. Pereira, D. Barata, J. Zhang, 
V. LaPointe, R. Truckenmuller, C. Bao, X. Xu, P. Habibovic, Acta 
Biomateralia 2016, 42, 364.
[101] X. Li, C. A. van Blitterswijk, Q. Feng, F. Cui, F. Watari, Biomaterials 
2008, 29, 3306.
[102] P. Mazón, D. García-Bernal, L. Meseguer-Olmo, F. Cragnolini, 
P. N. De Aza, Ceram. Int. 2015, 41, 6631.
[103] F. Khan, M. Tanaka, S. R. Ahmad, J. Mater. Chem. B 2015, 3, 
8224.
[104] M. G. Holthaus, L. Treccani, K. Rezwan, J. Eur. Ceram. Soc. 2011, 
31, 2809.
[105] D. Barata, A. Resmini, D. Pereira, S. A. Veldhuis, 
C. A. van Blitterswijk, J. E. ten Elshof, P. Habibovic, J. Mater. 
Chem. B 2016, 4, 1044.
[106] A. Pelaez-Vargas, D. Gallego-Perez, A. Carvalho, M. H. Fernandes, 
D. J. Hansford, F. J. Monteiro, J. Biomed. Mater. Res., Part B 2013, 
101, 762.
[107] Y. He, X. Wang, L. Chen, J. Ding, J. Mater. Chem. B 2014, 2, 2220.
[108] M. Descamps, T. Duhoo, F. Monchau, J. Lu, P. Hardouin, 
J. C. Hornez, A. Leriche, J. Eur. Ceram. Soc. 2008, 28, 149.
[109] H. Yuan, M. v. d. Doel, S. Li, C. A. v. Blitterswijk, K. d. Groot, 
J. D. d. Bruijn, J. Mater. Sci.: Mater. Med. 2002, 13, 1271.
[110] P. Habibovic, T. M. Sees, M. A. v. d. Doel, C. A. v. Blitterswijk, 
K. d. Groot, J. Biomed. Mater. Res., Part A 2006, 77A, 747.
[111] M. Yetmez, Adv. Mater. Sci. Eng. 2014, 2014, 1.
[112] E. Champion, Acta Biomateralia 2013, 9, 5855.
[113] P. Habibovic, H. Yuan, C. M. van der Valk, G. Meijer, 
C. A. van Blitterswijk, K. de Groot, Biomaterials 2005, 26, 3565.
[114] K. M. Nuss, J. A. Auer, A. Boos, B. von Rechenberg, BMC 
Musculoskelet. Disord. 2006, 7, 67.
[115] Y. Hong, H. Fan, B. Li, B. Guo, M. Liu, X. Zhang, Materials Science 
and Engineering: R: Reports 2010, 70, 225.
[116] B. Feng, Z. Jinkang, W. Zhen, L. Jianxi, C. Jiang, L. Jian, M. Guolin, 
D. Xin, Biomed. Mater. 2011, 6, 015007.
[117] S. Bose, S. Vahabzadeh, A. Bandyopadhyay, Mater. Today 2013, 16, 
496.
[118] R. Trombetta, J. A. Inzana, E. M. Schwarz, S. L. Kates, H. A. Awad, 
Ann. Biomed. Eng. 2016.
[119] S. Tarafder, V. K. Balla, N. M. Davies, A. Bandyopadhyay, S. Bose, 
J. Tissue Eng. Regen. Med. 2013, 7, 631.
[120] S. H. Jariwala, G. S. Lewis, Z. J. Bushman, J. H. Adair, 
H. J. Donahue, 3D Printing and Additive Manufacturing 2015, 2, 56.
[121] A. S. Rowlands, P. A. George, J. J. Cooper-white, American Journal 
of Physiology. Cell Physiol. 2008, 295, 1037.
[122] W. L. Murphy, T. C. McDevitt, A. J. Engler, Nat. Mater. 2014, 13, 
547.
[123] Y. R. Shih, K. F. Tseng, H. Y. Lai, C. H. Lin, O. K. Lee, J. Bone Miner. 
Res. 2011, 26, 730.
[124] M. M. Gentleman, E. Gentleman, Int. Mater. Rev. 2014, 59, 417.
[125] L. Hao, J. Lawrence, Colloids and Surfaces B, Biointerfaces 2004, 
34, 87.
[126] S. B. Kennedy, N. R. Washburn, C. G. Simon Jr., E. J. Amis, 
Biomaterials 2006, 27, 3817.
[127] D. Aronov, R. Rosen, E. Z. Ron, G. Rosenman, Process Biochem. 
2006, 41, 2367.
[128] R. Z. LeGeros, Chem. Rev. 2008, 108, 4742.
Adv. Healthcare Mater. 2017, 6, 1601478
1601478 (15 of 15)
www.advancedsciencenews.com www.advhealthmat.de
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimAdv. Healthcare Mater. 2017, 6, 1601478
[129] F. Barrère, M. Ni, P. Habibovic, P. Ducheyne, K. d. Groot, in Tissue 
Engineering, Academic Press, Burlington 2008, 223.
[130] H. Yuan, C. A. van Blitterswijk, K. de Groot, J. D. de Bruijn, 
J. Biomed. Mater. Res., Part A 2006, 78, 139.
[131] M. M. Dvorak, A. Siddiqua, D. T. Ward, D. H. Carter, S. L. Dallas, 
E. F. Nemeth, D. Riccardi, Proc. Natl. Acad. Sci. USA 2004, 101, 5140.
[132] P. J. Marie, Bone 2010, 46, 571.
[133] Z. Meleti, I. Shapiro, C. Adams, Bone 2000, 27, 359.
[134] R. Zhang, Y. Lu, L. Ye, B. Yuan, S. Yu, C. Qin, Y. Xie, T. Gao, 
M. K. Drezner, L. F. Bonewald, J. Q. Feng, J. Bone Miner. Res. 2011, 
26, 1047.
[135] C. J. Damien, J. R. Parsons, J. Appl. Biomater. 1991, 2, 187.
[136] S. Kannan, S. Pina, J. M. F. Ferreira, J. Am. Ceram. Soc. 2006, 89, 
3277.
[137] L. Yang, S. Perez-Amodio, F. Y. Barrere-de Groot, V. Everts, 
C. A. van Blitterswijk, P. Habibovic, Biomaterials 2010, 31, 2976.
[138] M. Bohner, Biomaterials 2009, 30, 6403.
[139] Z. Tahmasebi Birgani, E. Fennema, M. J. Gijbels, J. de Boer, 
C. A. van Blitterswijk, P. Habibovic, Acta Biomateralia 2016, 36, 267.
[140] J. Barralet, U. Gbureck, P. Habibovic, E. Vorndran, C. Gerard, 
C. J. Doillon, Tissue Eng.,Part A 2009, 15, 1601.
[141] Z. T. Birgani, A. Malhotra, C. A. van Blitterswijk, P. Habibovic, 
J. Biomed. Mater. Res., Part A 2016, 104, 1946.
[142] Z. T. Birgani, B. J. Klotz, C. A. V. Blitterswijk, P. Habibovic, 
Advanced Biomaterials and Devices in Medicine 2014, 1, 1.
[143] W. N. Addison, F. Azari, E. S. Sorensen, M. T. Kaartinen, 
M. D. McKee, J. Biol. Chem. 2007, 282, 15872.
[144] L. A. Rezende, P. Ciancaglini, J. M. Pizauro, F. A. Leone, Cell. Mol. 
Biol. 1998, 44, 293.
[145] S. Jonos, M. D. McKee, C. E. Murry, A. Shoi, Y. Nishizawa, K. Mori, 
H. Morii, C. M. Giachelli, Circ. Res. 2000, 87, E10.
[146] P. Habibovic, D. C. Bassett, C. J. Doillon, C. Gerard, M. D. McKee, 
J. E. Barralet, Advanced Materials (Deerfield Beach, Fla.) 2010, 22, 
1858.
[147] A. M. Barradas, H. A. Fernandes, N. Groen, Y. C. Chai, J. Schrooten, 
J. van de Peppel, J. P. van Leeuwen, C. A. van Blitterswijk, 
J. de Boer, Biomaterials 2012, 33, 3205.
[148] Y. C. Chai, S. J. Roberts, J. Schrooten, F. P. Luyten, Tissue Eng., Part 
A 2011, 17, 1083.
[149] M. Schumacher, A. S. Wagner, J. Kokesch-Himmelreich, A. Bernhardt, 
M. Rohnke, S. Wenisch, M. Gelinsky, Acta Biomateralia 2016, 37, 
184.
[150] S. H. Hyon, Yonsei Med. J. 2000, 41, 720.
[151] N. L. S. Nair, C. T. Laurencin, Prog. Polymer Sci. 2007, 32, 762.
[152] M. A. Lopez-Heredia, P. Weiss, P. Layrolle, J. Mater. Sci.: Mater. 
Med. 2007, 18, 381.
[153] Y. Liu, G. Wu, K. de Groot, J. R. Soc. Interface 2010, 7, Suppl 5, 
S631.
[154] P. Habibovic, C. M. Van Der Valk, C. a. Van Blitterswijk, 
K. De Groot, G. Meijer, J. Mater. Sci.: Mater. Med. 2004, 15, 373.
[155] P. Habibovic, J. Li, C. M. van der Valk, G. Meijer, P. Layrolle, 
C. A. van Blitterswijk, K. de Groot, Biomaterials 2005, 26, 23.
[156] F. Barrére-de Groot, P. Layrolle, C. A. van Blitterswijk, K. de Groot, 
J. Mater. Sci.: Mater. Med. 2001, 12, 529.
[157] G. A. Burke, C. J. Rea, F. G. Horgan, M. Turkington, A. R. Boyd, 
B. J. Meenan, J. Mater. Sci. Mater. Med. 2012, 23, 835.
[158] X. Hu, H. Shen, Y. Cheng, X. Xiong, S. Wang, J. Fang, S. Wei, 
Surface Coatings Technol. 2010, 205, 2000.
[159] B. A. van Oirschot, R. M. Eman, P. Habibovic, S. C. Leeuwenburgh, 
Z. Tahmasebi, H. Weinans, J. Alblas, G. J. Meijer, J. A. Jansen, 
J. J. van den Beucken, Acta Biomateralia 2016, 37, 195.
[160] J. G. Wolke, K. d. Groot, J. A. Jansen, J. Biomed. Mater. Res., Part A 
1998, 39, 524.
[161] K. D. Park, Y. S. Jung, K. K. Lee, H. J. Park, J. Craniofac. Surg. 2016, 
27, 898.
[162] S. Di Cio, J. E. Gautrot, Acta Biomateralia 2016, 30, 26.
[163] T. Sjostrom, M. J. Dalby, A. Hart, R. Tare, R. O. Oreffo, B. Su, Acta 
Biomateralia 2009, 5, 1433.
[164] A. Bruinink, M. Bitar, M. Pleskova, P. Wick, H. F. Krug, 
K. Maniura-Weber, J. Biomed. Mater. Res., Part A 2014, 102, 275.
[165] A. S. Curtis, M. Dalby, N. Gadegaard, Nanomedicine 2006, 1, 67.
[166] H. Wu, R. Zhang, X. Li, J. Ni, C. Zhao, Y. Song, J. Wang, 
S. Zhang, Y. Zheng, X. Zhang, Prog. Nat. Sci.: Mater. Int. 2014, 24, 
479.
